Patent · US Expired

Multimeric Apo A-I agonist compounds

US7307058B2 · kind B2 · utility

7Cited by
0References
23Claims
0Family size

Inventors

Key dates

Filing dateNov 17, 2003
Grant dateDec 11, 2007
Priority date
Expiry dateApr 25, 2025

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K7/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides peptides and peptide analogues that mimic the structural and pharmacological properties of human ApoA-I. The peptides and peptide analogues are useful to treat a variety of disorders associated with dyslipidemia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.